€8.36
1.82% yesterday
Madrid, Nov 15, 05:35 pm CET
ISIN
ES0157097017
Symbol
ALM
Sector
Industry

Almirall Stock price

€8.36
-0.63 7.01% 1M
-1.02 10.87% 6M
-0.07 0.77% YTD
-0.03 0.30% 1Y
-2.94 26.02% 3Y
-6.94 45.36% 5Y
-4.25 33.69% 10Y
Madrid, Closing price Fri, Nov 15 2024
-0.16 1.82%
ISIN
ES0157097017
Symbol
ALM
Sector
Industry

Key metrics

Market capitalization €1.82b
Enterprise Value €1.88b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 27.48
EV/Sales (TTM) EV/Sales 2.03
P/S ratio (TTM) P/S ratio 1.96
P/B ratio (TTM) P/B ratio 1.22
Dividend yield 2.16%
Last dividend (FY24) €0.18
Revenue growth (TTM) Revenue growth 3.70%
Revenue (TTM) Revenue €925.67m
EBIT (operating result TTM) EBIT €38.83m
Free Cash Flow (TTM) Free Cash Flow €68.41m
EPS (TTM) EPS €-0.17
P/E forward 93.78
P/S forward 1.87
EV/Sales forward 1.93
Show more

Is Almirall a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Almirall Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Almirall forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Almirall forecast:

Buy
70%
Hold
30%

Financial data from Almirall

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
926 926
4% 4%
100%
- Direct Costs 563 563
8% 8%
61%
363 363
2% 2%
39%
- Selling and Administrative Expenses 118 118
4% 4%
13%
- Research and Development Expense 75 75
10% 10%
8%
169 169
5% 5%
18%
- Depreciation and Amortization 130 130
5% 5%
14%
EBIT (Operating Income) EBIT 39 39
29% 29%
4%
Net Profit -35 -35
218% 218%
-4%

In millions EUR.

Don't miss a Thing! We will send you all news about Almirall directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Carlos Piqué
Employees 1,904
Founded 1995
Website www.almirall.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today